Trial Comparing Treatment With SInergy™ System to Conservative Treatment for Chronic Sacroiliac Joint Pain

Not Applicable

Terminated

• Conditions: Chronic Sacroiliac Joint Pain
• Interventions: Device: Treatment with SInergy™ System; Other: Conservative Treatment

• Registration Number: NCT01158092
• Lead Sponsor: Baylis Medical Company

Brief Summary

The purpose of this study is to evaluate the effectiveness of cooled radiofrequency denervation of the sacroiliac region using the SInergy System compared to conservative treatment in the treatment of sacroiliac joint pain.

Detailed Description

Not available

Study Timeline

• Study Start: 2010-07
• Study First Submitted: 2010-07-06
• Study First Submitted QC: 2010-07-07
• Study First Posted: 2010-07-08
• Primary Completion: 2012-03
• Status Verified: 2013-05
• Last Update Submitted: 2013-05-03
• Last Update Posted: 2013-05-06

Recruitment & Eligibility

• Status: TERMINATED
• Sex: All
• Target Recruitment: 5

Inclusion Criteria

• Predominantly axial pain below the L5 vertebrae
• >75% pain relief from 2 separate lateral branch blocks done on different days (followed by return to baseline pain)
• Chronic axial pain lasting for longer than six months: 3 day average VAS between 4 and 8.
• Age greater than 18 years.
• Failed to achieve adequate improvement with comprehensive non-operative treatments, including but not limited to: activity alteration, non-steroidal anti-inflammatory, physical and/or manual therapy, and fluoroscopically guided steroid injections in and around the area of pathology.
• All other possible sources of low back pain have been ruled out, including but not limited to: the intervertebral discs, bone fracture, the zygapophyseal joints, the hip joint, symptomatic spondylolisthesis, tumor and other regional soft tissue structures (this is done by physical exam, medical history, and MRI/CT/X-ray as required)

Exclusion Criteria

• Beck Depression Score >20 or irreversible psychological barriers to recovery
• Spinal pathology that may impede recovery such as spina bifida occulta, spondylolisthesis at L5/S1, or scoliosis.
• Moderate or severe foraminal or central canal stenosis
• Systemic infection or localized infection at anticipated introducer entry site.
• Concomitant cervical or thoracic pain greater than 2/10 on a VAS
• Uncontrolled or acute illness
• Chronic severe conditions such as rheumatoid/inflammatory arthritis
• Pregnancy
• Active radicular pain
• Immunosuppression (eg. AIDS, cancer, diabetes, surgery <3 months ago)
• Worker's compensation, injury litigation, or disability remuneration
• Allergy to injectants or medications used in procedure
• High narcotics use (>30 mg hydrocodone or equivalent)
• Patients who smoke. Termination for at least 6 months and no smoking during follow up period are acceptable with caution.
• Body Mass Index greater than 29.9 (obese).
• Subject unwilling to consent to the study

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: PARALLEL

Arm && Interventions

Group	Intervention	Description
Treatment with SInergy™ System	Treatment with SInergy™ System	Lateral branch denervation using the SInergy™ System
Conservative Treatment	Conservative Treatment	Treatment with physical therapy, chiropractic care, and medication

Primary Outcome Measures

Name	Time	Method
Pain status change for sacroiliac region pain intensity assessed using visual analogue scale (VAS)	12 months

Secondary Outcome Measures

Name	Time	Method
Change in bodily pain evaluated using SF-36 Bodily Pain	12 months
Change in physical functioning evaluated using SF-36 Physical Function	12 months
Change in disability evaluated using Oswestry Disability Index 2.0	12 months
Change in quality of life using the Assessment of Quality of Life (AQOL)	12 months

Trial Locations

Locations (1)

Brigham and Women's Hospital Pain Trials Center; 🇺🇸 Chestnut Hill, Massachusetts, United States